stars 1 stars 2 stars 3

Biomanufacturing is scaling. Analytics are not. InSpek brings real-time molecular visibility into bioprocesses across biomanufacturing, pharmaceuticals, and industrial biotech. The problem: Most processes still rely on intermittent sampling, offline analysis, and delayed feedback. This creates blind spots: deviations detected too late, scale-up failures, batch losses costing millions. What we do: Our integrated sensing systems provide continuous, in-line molecular monitoring directly inside bioreactors. Teams get high-frequency data on metabolites, process conditions, and molecular dynamics. The impact: - Detect deviations hours earlier - 20-80% yield improvements - Reduce batch risk and development time - Scale from bench to production with confidence Who we serve: - Bioprocessing & biomanufacturing - Pharmaceutical manufacturing - Process development & scale-up - Industrial biotech & precision fermentation The future: We are building the sensing infrastructure behind data-driven biomanufacturing with a roadmap toward multi-parameter sensing, integrated interpretation, and intelligent process optimization.

InSpek Questions

Jérôme Michon is the Co-Founder and CEO of InSpek.

11 people are employed at InSpek.

InSpek is based in Suresnes, Île-de-France.

Top InSpek Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users